Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Legal Litigation topic
No spam. Unsubscribe anytime.
Committee directs acting co‑administrator to proceed after closed session; resolution to add defendants to pharmaceutical lawsuit forwarded to full board
Summary
The Sawyer County Administrative Committee voted to enter closed session under Wis. Stat. §19.85(1)(g) to confer with legal counsel about anticipated litigation and later directed Acting Co‑Administrator Mike Markran to implement the actions discussed there.
The Sawyer County Administrative Committee voted to go into closed session under state law to confer with legal counsel on likely litigation and later directed the acting co‑administrator to pursue the actions discussed there.
The committee invoked the closed‑session authority under section 19.85(1)(g) of the Wisconsin Statutes, which permits a governmental body to confer with counsel about litigation strategy. The roll call to enter closed session recorded Ron Kinsley, Ron Buchholz and Tom Duffy voting “yes”; John Regheimer was excused; the motion passed.
After the closed session, the committee reconvened in open session and approved a motion directing Mike Markran, acting co‑administrator, to move forward with the actions discussed in closed session. Committee members voted in favor; the chair declared the motion carried.
Separately, the committee considered a resolution related to Sawyer County’s participation in multi‑county litigation involving pharmaceutical companies. Committee staff said the resolution was circulated on the recommendation of Andy Phillips; the committee approved and forwarded the resolution to the full county board for consideration.
Why it matters: the committee’s closed‑session directive authorizes county staff to take steps tied to litigation strategy; forwarding the resolution to the board signals continued county participation in coordinated legal action involving pharmaceutical manufacturers and vendors.
What was decided: the committee approved forwarding the resolution adding defendants to the broader pharmaceutical litigation to the full board and formally directed the acting co‑administrator to take the steps discussed during closed session.
